Results 101 to 110 of about 37,692 (229)
Itraconazole therapy for nonmeningeal coccidioidomycosis:Clinical and laboratory observations
, 1990 Itraconazole, a new oral triazole antifungal agent, was administered in 75 courses to patients with chronic coccidioidomycosis at dosages of 50 to 400 mg/day for a median duration of 10 months.
Stevens, David A. +4 more
core +1 more source
Peumus boldus: Revealing the Pharmaceutical Potential of the Chilean Forest
Chemistry &Biodiversity, Volume 23, Issue 10, October 2026.P. boldus emerge as a promising yet underexplored source of bioactive compounds. Current evidence highlights antioxidant, anti‐inflammatory, antimicrobial, and cytoprotective activities associated with their unique phytochemical profile. This review integrates chemical composition, biological properties, proposed molecular mechanisms, and safety ...
Marta Rodríguez‐Ceballos +8 more
wiley +1 more source
Pharmaceutical Compounding in Veterinary Medicine: Suspension of Itraconazole
PharmaceuticsItraconazole is a drug used in veterinary medicine for the treatment of different varieties of dermatophytosis at doses between 3–5 mg/kg/day in cats. Nevertheless, in Spain, it is only available in the market as a 52 mL suspension at 10 mg/mL.
Gema J. Cabañero-Resta +6 more
doaj +1 more source
White Nodes on the Hair Shaft of a 16‐Year‐Old Swimmer
Pediatric Dermatology, EarlyView.
Sarah Hallowell, Michelle Oboite
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 10, October 2026.ABSTRACT Low phospholipid‐associated cholelithiasis (LPAC) syndrome is a rare inherited disorder caused by ABCB4 mutations with heterogeneous manifestations. We describe two LPAC cases in a mother–son pair, detailing their clinical presentations, diagnostic evaluations, and management. A novel ABCB4 frameshift variant (c.715_716insTT; p.Ser239PhefsTer9)
Hui‐Ming Yang, Jun Liu, Zheng Zhang
wiley +1 more source
, 2018 Empirical antifungal therapy; Hematological malignancy; Hydroxy itraconazole; itraconazole; Therapeutic drug ...
문영철
core +1 more source
Toxicity of Antifungal Drugs Itraconazole and Fluconazole in Rats [PDF]
, 2004 Itraconazole and Fluconazole are the newer antifungal drugs that have been used for several years. Both these drugs have a broad-spectrum antifungal activity and currently are used to treat infections caused by Candida albicans, Aspergillus spp ...
Abdul Rahman, Nor Shahida
core +1 more source
Clinical Case Reports, Volume 14, Issue 10, October 2026.ABSTRACT Rhino‐orbital mucormycosis can present aggressively in immunocompetent adults, often with atypical initial symptoms that lead to misdiagnosis and dangerous delays. A high index of suspicion is paramount when facing a rapidly progressive orbital infection unresponsive to conventional therapy.
Seyed Mohammad Mousavi +5 more
wiley +1 more source
Digoxin–Itraconazole Interaction: Possible Mechanisms
, 1997 Objective To document a case in which the administration of itraconazole was associated with an apparent decrease in digoxin clearance, resulting in an increase in the serum digoxin concentration.
Christopher P Alderman, Peter D Allcroft
core +1 more source
, 2002 Background. The double action - antimycotic and anti-inflammatory - of itraconazole, has opened new horizons in the treatment of a number of inflammatory skin disorders in which Malassezia yeasts seem to play a pathogenetic role. Methods.
M. Barbareschi +3 more
core +1 more source